Abstract
While angiotensinogen (AGT) seems to have anti proliferative properties, angiotensin II (ATII) is a potent growth factor and it mediates its actions through the angiotensin type 1 receptor (AGTR1). In the AGT gene, the M235T polymorphism has been associated with the variation in angiotensinogen levels and in the AGTR1 gene; the C573T variant is associated with different pathologies. We aimed to evaluate the relationship of these two variants and the risk of breast cancer. These polymorphisms were genotyped in 3787 women participating the Rotterdam Study. We performed a logistic regression and a disease free survival analysis by genotype. The logistic regression yielded an odds ratio of 1.4 (95% CI: 1.1–1.9) for the MM genotype carriers versus the T allele carriers. The breast cancer free survival by AGT genotype was significantly reduced in MM genotype carriers compared to non-carriers (hazard ratio (HR) = 1.5; 95% CI: 1.1–2.2). We did not find any association of the AGTR1 polymorphism and breast cancer risk or disease free survival. Our results suggest that AGT plays a role in breast cancer risk in postmenopausal women, whereas the role of AGTR1 needs further studying.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bernstein L (2002) Ethnicity-related variation in breast cancer risk factors. Cancer 97:222–229
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18
Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J (2001) Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38:1382–1387
Muscella A, Greco S, Elia MG, Storelli C, Marsigliante S (2002) Angiotensin II stimulation of Na+/K + ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 173:315–323
Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M (2003) Differential regulation of in vivo angiogenesis by angiotensin II receptors. Faseb J 17:2061–2067
Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P (2002) Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 39:224–228
Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Marsigliante S (2002) Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. J␣Endocrinol 174:205–214
Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S (2003) Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol 196:370–377
Gonzalez-Zuloeta Ladd AM, Vasquez AA, Sayed-Tabatabaei␣FA, Coebergh JW, Hofman A, Njajou O, Stricker B, van Duijn C (2005) Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2143–2146
Greco S, Elia MG, Muscella A, Storelli C, Marsigliante S (2002) AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. Cell Calcium 32:1–10
Gould AB, Green D (1971) Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5:86–89
Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S et al. (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4:59–61
Vinck WJ, Fagard RH, Vlietinck R, Lijnen P (2002) Heritability of plasma renin activity and plasma concentration of angiotensinogen and angiotensin-converting enzyme. J Hum Hypertens 16:417–422
Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH (1995) The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948–953
Bennett CL, Schrader AP, Morris BJ (1993) Cross-sectional analysis of Met235–> Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 197:833–839
Jeunemaitre X, Gimenez-Roqueplo AP, Celerier J, Corvol P (1999) Angiotensinogen variants and human hypertension. Curr Hypertens Rep 1:31–41
Morgan L, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N (2000) Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women. J Hypertens 18:553–537
Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169–180
Su S, Chen J, Zhao J, Huang J, Wang X, Chen R, Gu D (2004) Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study. Pharmacogenetics 14:673–681
Chaves FJ, Pascual JM, Rovira E, Armengod ME, Redon J (2001) Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. Am J Hypertens 14:364–370
De Paepe B, Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR (2001) Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 116:247–254
Duncan JA, Scholey JW, Miller JA (2001) Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111–116
Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112:67–75
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403–422
Garrow J (1986) Quetelet index as indicator of obesity. Lancet 1:1219
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Raymond MRF (1986) Genepop (version 1.2): population genetics software for exact tests and ecumenism. J Heredity 86:248–249
Corvol P, Jeunemaitre X (1997) Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 18:662–677
Azizi M, Hallouin MC, Jeunemaitre X, Guyene TT, Menard J (2000) Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration. J Clin Endocrinol Metab 85:4331–4337
Chaves FJ, Giner V, Corella D, Pascual J, Marin P, Armengod ME, Redon J (2002) Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord 26:1173–1178
Prat-Larquemin L, Oppert JM, Clement K, Hainault I, Basdevant A, Guy-Grand B, Quignard-Boulange A (2004) Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients. Obes Res 12:556–561
Brand E, Chatelain N, Paillard F, Tiret L, Visvikis S, Lathrop M, Soubrier F, Demenais F (2002) Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 10:715–723
Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, Asai T, Fukuda M, Suzuki F, Nakamura Y, Higaki J, Ogihara T (2000) Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 68:259–272
Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786–1797
Chaves FJ, Corella D, Sorli JV, Marin-Garcia P, Guillen M, Redon J (2004) Polymorphisms of the renin-angiotensin system influence height in normotensive women in a Spanish population. J Clin Endocrinol Metab 89:2301–2305
Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108–115
Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63–69
Redon J, Luque-Otero M, Martell N, Chaves FJ (2005) Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients. Pharmacogenomics J 5:14–20
Poirier O, Georges JL, Ricard S, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F, Tiret L (1998) New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde. J Hypertens 16:1443–1447
Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC (2004) Polymorphisms in angiotensin II type 1 receptor (AGTR1) and angiotensin I-converting enzyme (ACE) genes and breast cancer risk among chinese women in Singapore. Carcinogenesis
Acknowledgments
A. Arias Vasquez is supported by a grant from the Centre of Medical Systems Biology, grant # 297–2003. The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam, the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam.
These sponsors had no role in study design, data collection, data interpretation, or the writing of this report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ladd, A.M.GZ., Vásquez, A.A., Siemes, C. et al. Differential Roles of Angiotensinogen and Angiotensin Receptor type 1 Polymorphisms in Breast Cancer Risk. Breast Cancer Res Treat 101, 299–304 (2007). https://doi.org/10.1007/s10549-006-9290-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-006-9290-0